E2F4-BASED GENE THERAPY MITIGATES THE IMMUNE RESPONSE OF THE ALZHEIMER’S DISEASE MOUSE MODEL 5XFAD

• Morgan Ramón Landreau,
• Noelia López-Sánchez,
• Alberto Garrido García,
• Vanesa Cano Daganzo,
• Jose María Frade

Affiliations

Morgan Ramón Landreau

Tetraneuron, S. L., I + D, Madrid, Spain

Noelia López-Sánchez

Tetraneuron, S. L., I+d, Madrid, Spain

Alberto Garrido García

Tetraneuron, S. L., I+d, Madrid, Spain

Vanesa Cano Daganzo

Tetraneuron, S. L., I+d, Madrid, Spain

Jose María Frade

Cajal Institute (CSIC), Molecular, Cellular And Developmental Neurobiology, Madrid, Spain